PortfoliosLab logoPortfoliosLab logo
PJP vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PJP vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


PJP

1D
1.20%
1M
1.29%
YTD
2.90%
6M
2.29%
1Y
34.73%
3Y*
13.31%
5Y*
7.62%
10Y*
6.15%

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PJP vs. GERM - Yearly Performance Comparison


2026 (YTD)20252024
PJP
Invesco Dynamic Pharmaceuticals ETF
2.90%27.98%-3.47%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%

PJP vs. GERM - Sectors Allocation Comparison


Sectors
PJP
GERM

Healthcare

100.0%
99.3%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

0.4%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

PJP
100.0%
GERM
99.3%

Basic Materials

PJP

-

GERM

-

Communication Services

PJP

-

GERM

-

Consumer Cyclical

PJP

-

GERM

-

Consumer Defensive

PJP

-

GERM

-

Energy

PJP

-

GERM

-

Financial Services

PJP

-

GERM
0.4%

Industrials

PJP

-

GERM

-

Real Estate

PJP

-

GERM

-

Technology

PJP

-

GERM

-

Utilities

PJP

-

GERM

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PJP vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP
PJP Risk / Return Rank: 6464
Overall Rank
PJP Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
PJP Sortino Ratio Rank: 6464
Sortino Ratio Rank
PJP Omega Ratio Rank: 5757
Omega Ratio Rank
PJP Calmar Ratio Rank: 7373
Calmar Ratio Rank
PJP Martin Ratio Rank: 6363
Martin Ratio Rank

GERM
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PJP vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PJPGERMDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.36

Calmar ratioReturn relative to maximum drawdown

3.70

Martin ratioReturn relative to average drawdown

11.55

PJP vs. GERM - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


PJPGERMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.13

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.47

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.34

Sharpe Ratio (All Time)

Calculated using the full available price history

0.59

Drawdowns

PJP vs. GERM - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for PJP and GERM.


Loading charts...

Drawdown Indicators


PJPGERMDifference

Max Drawdown

Largest peak-to-trough decline

-37.06%

0.00%

-37.06%

Max Drawdown (1Y)

Largest decline over 1 year

-9.44%

0.00%

-9.44%

Max Drawdown (3Y)

Largest decline over 3 years

-16.27%

Max Drawdown (5Y)

Largest decline over 5 years

-17.51%

Max Drawdown (10Y)

Largest decline over 10 years

-33.95%

Current Drawdown

Current decline from peak

-2.94%

0.00%

-2.94%

Average Drawdown

Average peak-to-trough decline

-8.85%

0.00%

-8.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.02%

0.00%

+3.02%

Volatility

PJP vs. GERM - Volatility Comparison

Invesco Dynamic Pharmaceuticals ETF (PJP) has a higher volatility of 5.33% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that PJP's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PJPGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.33%

0.00%

+5.33%

Volatility (6M)

Calculated over the trailing 6-month period

12.02%

0.00%

+12.02%

Volatility (1Y)

Calculated over the trailing 1-year period

16.38%

0.00%

+16.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.17%

0.00%

+16.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.39%

0.00%

+18.39%

PJP vs. GERM - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is lower than GERM's 0.68% expense ratio.


Dividends

PJP vs. GERM - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 0.99%, while GERM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PJP
Invesco Dynamic Pharmaceuticals ETF
0.99%0.98%0.97%1.01%0.95%0.81%0.75%0.77%1.12%0.65%0.91%5.49%

Frequently Asked Questions


PJP has higher volatility (5.33%) compared to GERM (0.00%). In terms of maximum drawdown, PJP dropped -37.06% vs GERM's 0.00%.

On 1-year performance, PJP leads with 34.73% vs 0.00% for GERM. On fees, PJP is cheaper at 0.58% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, PJP has performed better with a 34.73% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

PJP is cheaper with a 0.58% expense ratio, compared with 0.68% for GERM.

PJP has the higher dividend yield at 0.99%, compared with 0.00% for GERM.

PJP tracks Dynamic Pharmaceuticals Intellidex Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: Invesco and Amplify. Their fees differ too: 0.58% for PJP and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for PJP and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer